British Medical Journal (The BMJ)Natural Ovulation versus Programmed Regimens Before Frozen Embryo Transfer in Ovulatory Women

Chinese multicentre trial randomized 4,376 ovulatory women to natural ovulation versus programmed hormone replacement before frozen embryo transfer. The live birth rates were identical, but natural ovulation cut pre-eclampsia risk by 37% and postpartum hemorrhage by 68%. This is the largest randomized trial powered to assess obstetric complications in frozen embryo transfer cycles, providing definitive evidence that preconception hormonal environment affects maternal morbidity months later.

💊 CLINICAL CONSIDERATIONS

• Natural ovulation regimen achieved equal healthy live birth rates (41.6% vs 40.6%) but reduced pre-eclampsia by 37% among clinical pregnancies, predominantly late-onset subtype without severe features
• Maternal complications consistently lower with natural ovulation: early pregnancy loss dropped 20%, placental accreta spectrum reduced 49%, cesarean delivery decreased to 69.5% from 75.6%
• Postpartum hemorrhage dramatically reduced from 6.1% to 2.0% (relative risk 0.32), which was the largest safety signal in the trial, suggesting corpus luteum factors influence placental health
• Natural ovulation requires closer monitoring (follicle tracking, serial labs) and carries 16.2% cycle cancellation versus 11.5% with programmed regimens—higher patient burden but safer maternal outcomes
• Proposed mechanism: absence of corpus luteum in programmed cycles eliminates relaxin and vasoactive factors critical for maternal cardiovascular adaptation, increasing late-pregnancy placental complications

⚕️ PRACTICE APPLICATIONS

• Recommend natural ovulation as first-line for frozen embryo transfer in ovulatory women
• Prioritize natural regimens for patients age 38+, obesity, or hypertensive disorder history
• Counsel that natural cycles require more monitoring but reduce serious maternal complications
• Document higher cycle cancellation (16%) when setting expectations for natural protocols
• Continue current programmed protocols only when natural ovulation monitoring is not feasible

More in Maternal-Fetal Medicine